MRNA Forecast



Bearish<—>Bullish



80% Confidence




Bullish Case: MRNA's potential in mRNA therapies beyond COVID-19, including cancer and flu, remains promising, supported by high investor interest and ongoing R&D funding.




Bearish Case: Ongoing legal challenges, declining vaccine demand, and regulatory uncertainties pose significant risks, threatening financial stability and investor confidence.




Potential Outcomes:
1. Vaccine demand stabilizes at low levels (70%).

2. New vaccine success spurs growth (50%).

3. Legal losses impact reputation (30%).



May 10, 2025


Moderna Forecast

MRNA        Moderna
















Become a more profitable investor with AI optimized trading strategies






×

Chat with MRNA


 Ask any question about MRNA!